<DOC>
	<DOCNO>NCT00292838</DOCNO>
	<brief_summary>To investigate validity clinical model determine relative potency different preparation inhale corticosteroid use treatment asthma eosinophilic bronchitis without asthma .</brief_summary>
	<brief_title>Relative Potency Inhaled Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Sputum eosinophilia &gt; 3 % Adults age 1870 year History episodic wheeze , chest tightness , dyspnea cough within last 12 month . FEV1 ≥ 60 % predict Steroid naive 500 µg day beclomethasone equivalent . Able give write informed consent 1 . Recent asthma COPD exacerbation ( judged clinician ) due respiratory infection within last month 2 . Relevant seasonal allergen exposure within 4 week within course study 3 . Treatment prednisone antibiotic hospitalisation within past 6 week 4 . Other respiratory disease 5 . Women pregnant unwilling use appropriate contraception study 6 . Unable withhold shortacting ßagonist treatment 6 hour visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Eosinophilic bronchitis asthma</keyword>
	<keyword>Eosinophilic bronchitis without asthma</keyword>
</DOC>